Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer
CompletedOBSERVATIONAL
Enrollment
1,000
Participants
Timeline
Start Date
April 1, 2021
Primary Completion Date
February 1, 2025
Study Completion Date
February 1, 2025
Conditions
Breast Cancer
Trial Locations (1)
11941
King Hussein Cancer Center, Amman
All Listed Sponsors
lead
King Hussein Cancer Center
OTHER
NCT04920656 - Universal Genetic Testing Versus Guidelines-Directed Testing for Germline Pathogenic Variants Among Non-Western Patients With Breast Cancer | Biotech Hunter | Biotech Hunter